Magdalena Śmiech

6PUBLICATIONS
8CO-AUTHORS
Molecular targetsPredictive and prognostic markersHorticultural crop improvement (incl. selection and breeding)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 27, 2024
New CEACAM-targeting 2A3 single-domain antibody-based chimeric antigen receptor T-cells produce anticancer effects in vitro and in vivo.

Iga Jancewicz, Magdalena Śmiech, Magdalena Winiarska

|Jun 02, 2021
NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.

Effi Haque, Magdalena Śmiech, Kamila Łuczyńska

|Apr 30, 2021
Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets.

Vancha Harish, Effi Haque, Magdalena Śmiech

|Nov 17, 2020
Emerging BRAF Mutations in Cancer Progression and Their Possible Effects on Transcriptional Networks.

Magdalena Śmiech, Paweł Leszczyński, Hidetoshi Kono

Pageof 1